Literature DB >> 12782122

Genomic studies of gene expression: regulation of the Wilson disease gene.

Elena G Bochukova1, Andrew Jefferson, Michael J Francis, Anthony P Monaco.   

Abstract

Bacterial artificial chromosomes (BACs) have many advantages over other large-insert cloning vectors and have been used for a variety of genetic applications, including the final contigs of the human genome. We describe the utilization of a BAC construct to study gene regulation in a tissue culture-based system, using a 170-kb clone containing the entire Wilson disease (WND) locus as a model. A second BAC construct that lacked a putative negatively regulating promoter sequence was created. A nonviral method of gene delivery was applied to transfect three human cell lines stably with each construct. Our results show correct WND gene expression from the recombinant locus and quantification revealed significantly increased expression from the clone lacking the negative regulator. Comparison with conventional methods confirms the reliability of the genomic approach for thorough examination of gene expression. This experimental system illustrates the potential of BAC clones in genomic gene expression studies, new gene therapy strategies, and validation of potential molecular targets for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782122     DOI: 10.1016/s0888-7543(03)00093-4

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  2 in total

1.  Unexpected complexity in the haplotypes of commonly used inbred strains of laboratory mice.

Authors:  B Yalcin; J Fullerton; S Miller; D A Keays; S Brady; A Bhomra; A Jefferson; E Volpi; R R Copley; J Flint; R Mott
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

2.  An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism.

Authors:  Michael R Bowl; M Andrew Nesbit; Brian Harding; Elaine Levy; Andrew Jefferson; Emanuela Volpi; Karine Rizzoti; Robin Lovell-Badge; David Schlessinger; Michael P Whyte; Rajesh V Thakker
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.